GBR With L-PRF Bone Block in Early Healing Phase After Extraction
LPRF-GBR
Alveolar Ridge Augmentation Using GBR With L-PRF Bone Block in Early Healing Phase After Dental Extraction: a Consecutive Case Series
1 other identifier
interventional
15
1 country
1
Brief Summary
When the practitioners have to place an implant, it is necessary to have a sufficient amount of bone. This study propose to manage clinical situations by an approach using guided bone regeneration using an L-PRF bone block (composite graft composed of a xenograft, a membrane from the patient's blood and a collagenous membrane) after a short healing period of 6 to 8 weeks after tooth extraction. Alveolar ridge changes will be evaluated regarding soft and hard tissues up to 6 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 22, 2021
CompletedFirst Submitted
Initial submission to the registry
June 11, 2021
CompletedFirst Posted
Study publicly available on registry
July 13, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2022
CompletedJuly 13, 2021
July 1, 2021
1.2 years
June 11, 2021
July 2, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Gain in ridge width in millimeters
Volumetric analysis of hard tissue using CBCT. They will be performed before extraction (T0), before guided bone regeneration (T1) and 6 months after regeneration before implant placement (T2). The CBCT done at T0 will be used as a reference for comparison with the CBCT T1 and T2. A high-resolution scanning protocol will be used with fixed exposure parameters and the CBCT will be adjusted to the target area to allow a significant reduction in irradiation dose. The DICOMs (Digital Imaging and Communication in Medicine) will be analysed using a dedicated application. The images taken at different times will be superimposed with an automatic algorithm and compared by 2D and 3D volumetric measurements.
5 to 8 month after guided bone regeneration
Secondary Outcomes (5)
Volumetric changes of the soft tissue in millimeters
5 to 8 month after guided bone regeneration
Need or not of an additional grafting procedure (yes or no)
5 to 8 month after guided bone regeneration
Analysis of the implant's osseointegration (ISQ)
up to 12 months
Patient reported outcomes mesures (VAS Scale)
through study completion, an average of 1 year
Occurrence of an adverse effect
through study completion, an average of 1 year
Study Arms (1)
GBR with L-PRF bone block
EXPERIMENTALGuided bone regeneration using Leukocyte and platelet-rich fibrin
Interventions
Guided bone regeneration using an L-PRF bone block (composite graft composed of a xenograft, a membrane from the patient's blood and a collagenous membrane) after a short healing period of 6 to 8 weeks after tooth extraction
Eligibility Criteria
You may qualify if:
- To be over 18 years old.
- Be in good general health.
- Have at least one monoradicular tooth (premolar, canine or incisor) that must be extracted with the need for bone regeneration and one or more implants afterwards.
- Have a DPSI (Dutch Periodontal Screening Index) ≤ 2.
You may not qualify if:
- Being a smoker.
- Have "active" periodontal problems, have a DPSI \> 2.
- Have a contraindication to the insertion of an implant and/or oral surgery.
- Have an active inflammatory and/or autoimmune disease of the oral cavity.
- Treatment with immunosuppressants, corticosteroids or biphosphonates.
- Have a history of cancer, radiotherapy or chemotherapy for cancer within the last 5 years.
- Have insulin-dependent diabetes.
- Have a blood disorder.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinique Universitaires Saint-Luc
Brussels, 1200, Belgium
Study Officials
- PRINCIPAL INVESTIGATOR
Jérôme Lasserre
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 11, 2021
First Posted
July 13, 2021
Study Start
January 22, 2021
Primary Completion
April 1, 2022
Study Completion
October 1, 2022
Last Updated
July 13, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share